/images/headbanner/14-Ehs.jpg
Environmental, Health and Safety
Head Banner
We have a number of special initiatives:
  • We participate as full members in the Pharmaceutical Supply Chain Initiative and are guided by the principles that address five areas of responsible business practice: ethics, human rights and labor, health and safety, environment, and management systems. 

  • In addition to reducing emissions and employing environmentally friendly initiatives at our facilities, we are also leading advocates of green chemistries. These eco-friendly synthetic routes and processes – including biocatalysis, flow chemistry, solvent recovery and reduction, as well as material consumption protocols – are designed to increase process efficiency and reduce waste and toxins. 

  • We have an internal policy across all our sites to improve our annual process mass intensity (PMI). 

  • Recent investments in China include a fully closed sewage treatment system and regenerative thermal oxidizer (RTO). 

  • All of our chemical reactors use a fully enclosed containment design that is dust-free and odourless – from dispensing through to reactors, centrifuge and discharge. These systems eliminate contamination and greatly improve safety. 

  • We strictly adhere to pharmaceutical supply chain initiative (PSCI) principles. 

  • We have passed 50+ client EHS audits since 2016. 

  • 7 operating sites have passed ISO 27001 (Information Security Management System certification)

/images/aboutus/ehs-part2.jpg
Art2019_HeroArticle
/images/aboutus/ehs-part3.png
Our promises to health, safety and environmental care cover
Hero Banner
/images/aboutus/ehs-part4.jpg
  • Conducting formal process safety evaluations prior to manufacture
  • Providing thorough health and safety training programs for both employees and contractors
  • Conducting toxicological and risk assessments for all new introduced processes
  • Working with our suppliers and customers to minimize environmental impacts across the entire production and supply value chain
  • Reducing our overall usage of water, energy, waste production, and emissions
  • To enhance our delivery of EHS policies, we have created several bespoke groups to drive forward a culture of corporate citizenship, including EHS committee process safety management committee general manager representative and a standalone EHS department
Head Combine
中文
EN
  • Home 首页
  • {{menu.Name}} {{menu.Name}}
      • {{twoMenu.Name}} {{twoMenu.Name}}
        • {{threeMenu.Name}} {{threeMenu.Name}}
          • {{fourMenu.Name}}
    • {{twoMenu.Name}}
  • Home 首页
  • EN 中文

{{item.headBannerTitle}}

  • About Us
  • Leadership
  • Quality & Compliance
  • IP Protection
  • Facilities
  • Environmental, Health and Safety
  • About Us
  • Services and Solutions
  • News
  • Resources
  • Careers
  • Contact us

{{item.title}}

{{item.title}}

  • About Us
  • News
  • Resource
  • Careers
  • Contact Us

Services & Solutions

  • API Process Development & Manufacturing
  • Drug Product Development & Manufacturing
  • Oligonucleotide CRDMO Service
  • Peptide CDRMO Service
  • Analytical Development & Quality Control
  • Global Regulatory Affairs CMC Support
  • 关于我们
  • 新闻和活动
  • 资源中心
  • 职业发展
  • 联系我们

服务和解决方案

  • 原料药工艺研发与生产
  • 制剂工艺研发与生产
  • 寡核苷酸
  • 多肽服务
  • 分析开发与质量控制
  • 全球申报事务药学支持

领英

药明康德

Copyright © 2020 STA Pharmaceutical Co. Ltd. Privacy Policy 隐私策略 Terms of Use 使用条款 沪公网安备 31011502018943号